WO2009053742A3 - Salts of nefopam and their use in therapy - Google Patents
Salts of nefopam and their use in therapy Download PDFInfo
- Publication number
- WO2009053742A3 WO2009053742A3 PCT/GB2008/050979 GB2008050979W WO2009053742A3 WO 2009053742 A3 WO2009053742 A3 WO 2009053742A3 GB 2008050979 W GB2008050979 W GB 2008050979W WO 2009053742 A3 WO2009053742 A3 WO 2009053742A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nefopam
- therapy
- salts
- relates
- novel salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/22—Eight-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
This invention relates to novel salts of Nefopam, which may be suitable for use in therapy.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0721013.1A GB0721013D0 (en) | 2007-10-25 | 2007-10-25 | New Salts |
| GB0721013.1 | 2007-10-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2009053742A2 WO2009053742A2 (en) | 2009-04-30 |
| WO2009053742A3 true WO2009053742A3 (en) | 2009-07-23 |
Family
ID=38829977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB2008/050979 WO2009053742A2 (en) | 2007-10-25 | 2008-10-23 | Salts of nefopam and their use in therapy |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0721013D0 (en) |
| WO (1) | WO2009053742A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2940911B1 (en) * | 2009-01-13 | 2012-09-21 | Philippe Perovitch | FORMULATION FOR ORAL TRANSMUCOSAL ADMINISTRATION OF ANTALGIC AND / OR ANTI-SPASMODIC MOLECULES |
| CA2782472C (en) | 2009-12-15 | 2019-04-16 | The Hospital For Sick Children | Method of treating scars and beta-catenin-mediated disorders |
| US10736905B1 (en) | 2016-09-09 | 2020-08-11 | Shahin Fatholahi | Nefopam dosage forms and methods of treatment |
| US10736874B1 (en) | 2017-09-08 | 2020-08-11 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
| US11446311B2 (en) | 2017-09-08 | 2022-09-20 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003105833A1 (en) * | 2002-06-17 | 2003-12-24 | Arakis Ltd. | Formulation of nefopam and its use in the treatment of pain |
| WO2005056539A2 (en) * | 2003-12-12 | 2005-06-23 | Arakis Ltd. | A process for the resolution of nefopam |
-
2007
- 2007-10-25 GB GBGB0721013.1A patent/GB0721013D0/en not_active Ceased
-
2008
- 2008-10-23 WO PCT/GB2008/050979 patent/WO2009053742A2/en active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003105833A1 (en) * | 2002-06-17 | 2003-12-24 | Arakis Ltd. | Formulation of nefopam and its use in the treatment of pain |
| WO2005056539A2 (en) * | 2003-12-12 | 2005-06-23 | Arakis Ltd. | A process for the resolution of nefopam |
Non-Patent Citations (1)
| Title |
|---|
| BOLT, A. G. ET AL: "Stereoselective demethylation of the enantiomers of nefopam, an experimental antidepressant and skeletal muscle relaxant", XENOBIOTICA , 4(6), 355-63 CODEN: XENOBH; ISSN: 0049-8254, 1974, XP002525368 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009053742A2 (en) | 2009-04-30 |
| GB0721013D0 (en) | 2007-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1007477A2 (en) | Method and well treatment composition | |
| WO2012088290A3 (en) | Tri-variable domain binding proteins and uses thereof | |
| LT3205334T (en) | METHOD AND COMPOSITION FOR THE TREATMENT OF EYE HYPERTENSION AND PROMOTION | |
| WO2010083385A3 (en) | Compounds for reducing drug resistance and uses thereof | |
| IL208027A0 (en) | Methods, compositions, and kits for treating pain and pruritus | |
| WO2009089494A3 (en) | Pharmaceutical compositions | |
| BRPI0814941A2 (en) | COMPOSITION OF SEED TREATMENT, AND, SEED TREATMENT METHOD. | |
| IL219107A0 (en) | 2-amino--5,5-difluoro-5,6-dihydro-4h-oxazines as bace 1 and/or bace 2 inhibitors | |
| ZA201103584B (en) | Whey protein compositions,methods and uses | |
| WO2009108730A3 (en) | Forms of rifaximin and uses thereof | |
| ZA201008450B (en) | Sweetener,methods of preparing sweetener and applications thereof | |
| ZA201103036B (en) | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith | |
| ZA201005278B (en) | Folates, compositions and uses thereof | |
| WO2011008092A3 (en) | Gram-positive bacteria specific binding compounds | |
| WO2009150255A3 (en) | Markers for predicting response and survival in anti-egfr treated patients | |
| IL207792A0 (en) | Methods, dosage forms, and kits for administering ziprasidone without food | |
| EP2340297A4 (en) | Composition, method of making the same, and use thereof | |
| AU2008263581A8 (en) | Well treatment | |
| BRPI0822129A2 (en) | Aldh-2c inhibitors in the treatment of addiction. | |
| WO2009053742A3 (en) | Salts of nefopam and their use in therapy | |
| WO2010017466A3 (en) | Phenobarbital salts; methods of making; and methods of use thereof | |
| IL195096A0 (en) | Aqueous tobacco leaf extract, uses thereof in the treatment of dependence | |
| WO2011067711A3 (en) | Novel heparanase splice variant | |
| BRPI0909302A2 (en) | reduction of conjugation plasmids in bacteria | |
| AU2009309277A8 (en) | Efficient expression of truncated human RNASET2 in E. Coli |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 08806786 Country of ref document: EP Kind code of ref document: A2 |